Skip to main content

CERA is led by a multi-disciplinary team with advanced expertise in genomics, bioethics, legal analysis, social science research, and related fields. The CERA leadership identifies priority areas in ELSI, ensures the integrity of our collection of ELSI resources and analysis, and guides the community building and engagement activities of the Center.

Steering Committee

The Steering Committee provides advice and oversight on resource prioritization and strategic planning matters. 

  • Teri Klein, Ph.D. ELSIhub Steering Committe

    Teri Klein, Ph.D.

    Teri Klein, Ph.D. is Professor in the Departments of Biomedical Data Sciences and Medicine / Division of Biomedical Informatics Research at Stanford University. She is Co-Principal Investigator of PharmGKB, a pharmacogenomics knowledge resource that annotates pharmacogenetic variants, curates drug dosing guidelines and FDA drug labels, summarizes important pharmacogenomics literature, and enables consortia, and, Co-Principal Investigator of CPIC, a pharmacogenetics consortium for the creation, curation and dissemination of peer-reviewed, evidence-based pharmacogenetics clinical practice guidelines.

  • David Magnus, Ph.D.  ELSIhub Steering Committee

    David Magnus, Ph.D.

    David Magnus, Ph.D. is the Director of the Stanford Center for Biomedical Ethics, and Thomas A. Raffin Professor of Medicine and Biomedical Ethics, as well as Professor of Pediatrics. He is the Vice-Chair of the NIH Precision Medicine Initiative “All of Us Research Program” IRB and is Editor-in-Chief of the American Journal of Bioethics and of

  • Nicole Lockhart, Ph.D. ELSIhub Steering Committe

    Nicole Lockhart, Ph.D.

    Nicole Lockhart, Ph.D. is Health Sciences Administrator of the Ethical, Legal, and Social Implications Research Program at the National Human Genome Research Institute (NHGRI). She manages a grant portfolio related to the ethical, legal and social (ELSI) implications of genomic research, including issues in the design and conduct of genomic research.

  • Dave Kaufman, Ph.D. ELSIhub Steering Committee

    Dave Kaufman, Ph.D.

    Dave Kaufman, Ph.D. is Program Director of the Ethical, Legal, and Social Implications Research Program at the National Human Genome Research Institute (NHGRI). He oversees a portfolio of research grants that address the ethical legal and social implications of integrating genomic information and technologies into clinical care, as well as issues of big data.

  • Josephine Johnston, L.L.B, M.B.H.L ELSIhub Steering Committe

    Josephine Johnston, L.L.B, M.B.H.L

    Josephine Johnston, L.L.B, M.B.H.L is Director of Research and a Research Scholar at the Hastings Center. Trained in law and bioethics, Ms. Johnston has led several projects on ELSI issues related to prenatal genetic testing, gene editing, and newborn sequencing. She is an expert on the ethical, legal, and policy implications of biomedical technologies, particularly as used in human reproduction, psychiatry, genetics, and neuroscience.

  • Wendy Chung, M.D., Ph.D. Steering Committee

    Wendy Chung, M.D., Ph.D.

    Wendy Chung, M.D., Ph.D. is a clinical and molecular geneticist and the Kennedy Family Professor of Pediatrics and Medicine and the Director of Clinical Research of SFARI at the Simons Foundation. She leads the Precision Medicine Resource in the Irving Institute at Columbia and serves on the Genomics and Pediatrics Advisory Committees for the All of Us Precision Medicine Initiative and NHGRI Council.